BE641880A - - Google Patents

Info

Publication number
BE641880A
BE641880A BE641880A BE641880A BE641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A BE 641880 A BE641880 A BE 641880A
Authority
BE
Belgium
Application number
BE641880A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE641880A publication Critical patent/BE641880A/xx

Links

BE641880A 1962-12-27 1963-12-27 BE641880A (en:Method)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5790262 1962-12-27
JP5741963 1963-10-29
JP6427663 1963-10-29
JP6250163 1963-11-22

Publications (1)

Publication Number Publication Date
BE641880A true BE641880A (en:Method) 1964-04-16

Family

ID=27463499

Family Applications (1)

Application Number Title Priority Date Filing Date
BE641880A BE641880A (en:Method) 1962-12-27 1963-12-27

Country Status (5)

Country Link
BE (1) BE641880A (en:Method)
FR (1) FR3150M (en:Method)
GB (1) GB1080599A (en:Method)
LU (1) LU45106A1 (en:Method)
NL (1) NL302572A (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2495608A1 (fr) * 1980-12-04 1982-06-11 Morelle Jean Nouveaux derives de l'acide aspartique et leurs usages
US8389576B2 (en) 2004-11-26 2013-03-05 Ucl Business Plc Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
DK3263100T3 (da) 2009-04-03 2020-05-11 Ocera Therapeutics Inc L-ornithinphenylacetat og fremgangsmåder til fremstilling deraf
DK2440200T3 (en) 2009-06-08 2014-12-08 Ucl Business Plc Treatment of portal hypertension in the application of l-ornithinphenylacetat
US8946473B2 (en) 2010-10-06 2015-02-03 Ocera Therapeutics, Inc. Methods of making L-ornithine phenyl acetate
ES2769000T3 (es) 2014-11-24 2020-06-24 Ucl Business Ltd Tratamiento de enfermedades asociadas con la activación de células estrelladas hepáticas utilizando terapias reductoras de amoníaco
US10835506B2 (en) 2015-08-18 2020-11-17 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
AU2018266357B2 (en) 2017-05-11 2022-12-08 Ocera Therapeutics, Inc. Processes of making L-ornithine phenylacetate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107540413A (zh) * 2017-09-14 2018-01-05 精晶药业股份有限公司 一种从门冬氨酸鸟氨酸结晶母液中提取尿素的方法

Also Published As

Publication number Publication date
FR3150M (fr) 1965-02-22
NL302572A (en:Method)
LU45106A1 (en:Method) 1964-02-24
GB1080599A (en) 1967-08-23

Similar Documents

Publication Publication Date Title
BE639390A (en:Method)
BE627090A (en:Method)
BE618896A (en:Method)
BE618984A (en:Method)
BE619189A (en:Method)
BE620075A (en:Method)
BE620714A (en:Method)
BE620803A (en:Method)
BE621745A (en:Method)
BE621772A (en:Method)
BE621826A (en:Method)
BE621920A (en:Method)
BE622246A (en:Method)
BE622273A (en:Method)
BE622611A (en:Method)
BE622801A (en:Method)
BE623479A (en:Method)
BE623636A (en:Method)
BE623747A (en:Method)
BE624034A (en:Method)
BE624244A (en:Method)
BE624314A (en:Method)
BE624412A (en:Method)
BE624520A (en:Method)
BE624971A (en:Method)